Pfizer Can't Escape Narrowed Off-Label Marketing FCA Suit

A Pennsylvania federal judge on Monday trimmed a False Claims Act suit against Pfizer Inc., but left room for the whistleblowers to refile and pursue other claims alleging illegal off-label marketing...

Already a subscriber? Click here to view full article